Monday, June 22, 2026

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Iran’s World Cup Preparations Hit by U.S. Visa Uncertainty and Mexico Base Camp Shift

Iran's national football team, set to participate in the 2026 World Cup, struggles with U.S. visa issues affecting training.

How Trump’s Iran Strategy Affects Samsung and SK Hynix: 3 Key Insights

Trump's announcement of strikes against Iran impacts semiconductor stocks, with Samsung and SK hynix experiencing significant losses.

Tag: immune diseases

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.